Safety and Efficacy of Imeglimin for Type 2 Diabetes Mellitus in Patients With Heart Failure

Authors

Institutions

Publication Details

Journal
In Vivo
Published
2024-12-31
DOI
https://doi.org/10.21873/invivo.13838
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Efficacy of Imeglimin for Type 2 Diabetes Mellitus in Patients With Heart Failure

Yusuke Akazawa, Akinori Higaki, Osamu Yamaguchi, Tomoaki Nishikawa et al.
1 citations
In Vivo
Diabetes Treatment and Management
0.36
article

Safety and Efficacy of Imeglimin for Type 2 Diabetes Mellitus in Patients With Heart Failure

Yusuke Akazawa, Akinori Higaki, Osamu Yamaguchi, Tomoaki Nishikawa, Shunsuke Tamaki, Toru Miyoshi, Ryusuke Horie, Tomoki Fujisawa, KEISHO KUROKAWA, KIMIHIRO YOSHIMOTO, Yoko M. Nakao, Hiroshi Kawakami, Shunichi Miyazaki, Kazuhide Inoue, Koji Nishimura, S Ikeda, Haruhiko Higashi
article en
1 citations

Abstract

No abstract available for this paper.
In VivoVol. 39(1)
Ehime University (JP)
Good health and well-being
Openalex Percentile: Top 30%
Diabetes Treatment and Management
0.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.